Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Laboratory data in clinical trials: a statistician's perspective.

Chuang-Stein C.

Control Clin Trials. 1998 Apr;19(2):167-77. Review.

PMID:
9551281
[PubMed - indexed for MEDLINE]
2.

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.

Chêne G, Morlat P, Leport C, Hafner R, Dequae L, Charreau I, Aboulker JP, Luft B, Aubertin J, Vildé JL, Salamon R.

Control Clin Trials. 1998 Jun;19(3):233-48.

PMID:
9620807
[PubMed - indexed for MEDLINE]
3.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

PMID:
12869717
[PubMed - indexed for MEDLINE]
Free Article
4.

Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials.

Yamaguchi T, Ohashi Y, Matsuyama Y.

Stat Methods Med Res. 2002 Jun;11(3):221-36.

PMID:
12094756
[PubMed - indexed for MEDLINE]
5.

A statistician's perspective on biomarkers in drug development.

Jenkins M, Flynn A, Smart T, Harbron C, Sabin T, Ratnayake J, Delmar P, Herath A, Jarvis P, Matcham J; PSI Biomarker Special Interest Group.

Pharm Stat. 2011 Nov-Dec;10(6):494-507. doi: 10.1002/pst.532. Epub 2011 Dec 8. Review.

PMID:
22162336
[PubMed - indexed for MEDLINE]
6.

Reporting adverse events in randomized controlled trials.

Nuovo J, Sather C.

Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):349-51.

PMID:
16998947
[PubMed - indexed for MEDLINE]
7.

Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).

Benjamin DM, Pendrak RF.

J Clin Pharmacol. 2003 Jul;43(7):754-9.

PMID:
12856390
[PubMed - indexed for MEDLINE]
8.

Threats to the validity of clinical trials employing enrichment strategies for sample selection.

Leber PD, Davis CS.

Control Clin Trials. 1998 Apr;19(2):178-87.

PMID:
9551282
[PubMed - indexed for MEDLINE]
9.

Meta-analysis and adverse drug reactions.

Mittmann N, Liu BA, Knowles SR, Shear NH.

CMAJ. 1999 Apr 6;160(7):987-8. No abstract available.

PMID:
10207335
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Alternative analytical methods for detecting matching effects in treatment outcomes.

Carbonari JP, Wirtz PW, Muenz LR, Stout RL.

J Stud Alcohol Suppl. 1994 Dec;12:83-90. Review.

PMID:
7723003
[PubMed - indexed for MEDLINE]
11.

The hope and the hazards of using compliance data in randomized controlled trials.

Pocock SJ, Abdalla M.

Stat Med. 1998 Feb 15;17(3):303-17.

PMID:
9493256
[PubMed - indexed for MEDLINE]
12.

Randomized clinical trial: myths around elementary statistical principles.

Edler L, Kopp-Schneider A.

Onkologie. 2003 Dec;26(6):551-6.

PMID:
14709929
[PubMed - indexed for MEDLINE]
13.

Stratified experiments reexamined with emphasis on multicenter trials.

Ganju J, Mehrotra DV.

Control Clin Trials. 2003 Apr;24(2):167-81. Erratum in: Control Clin Trials. 2003 Dec;24(6):830.

PMID:
12689738
[PubMed - indexed for MEDLINE]
14.

A potential competition bias in the detection of safety signals from spontaneous reporting databases.

Pariente A, Didailler M, Avillach P, Miremont-Salamé G, Fourrier-Reglat A, Haramburu F, Moore N.

Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1166-71. doi: 10.1002/pds.2022.

PMID:
20848561
[PubMed - indexed for MEDLINE]
15.

Interim analysis: the alpha spending function approach.

DeMets DL, Lan KK.

Stat Med. 1994 Jul 15-30;13(13-14):1341-52; discussion 1353-6.

PMID:
7973215
[PubMed - indexed for MEDLINE]
16.

Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.

Manchikanti L, Datta S, Smith HS, Hirsch JA.

Pain Physician. 2009 Sep-Oct;12(5):819-50.

PMID:
19787009
[PubMed - indexed for MEDLINE]
Free Article
17.

Specific barriers to the conduct of randomized trials.

Duley L, Antman K, Arena J, Avezum A, Blumenthal M, Bosch J, Chrolavicius S, Li T, Ounpuu S, Perez AC, Sleight P, Svard R, Temple R, Tsouderous Y, Yunis C, Yusuf S.

Clin Trials. 2008;5(1):40-8. doi: 10.1177/1740774507087704.

PMID:
18283079
[PubMed - indexed for MEDLINE]
18.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

PMID:
15361314
[PubMed - indexed for MEDLINE]
Free Article
19.

Reporting drug safety in clinical trials: getting the emphasis right.

Mucklow JC.

Lancet. 2001 May 5;357(9266):1384. No abstract available.

PMID:
11356432
[PubMed - indexed for MEDLINE]
20.

The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs.

Vray M, Hamelin B, Jaillon P; Round Table No.2, Giens XX.

Therapie. 2005 Jul-Aug;60(4):339-44, 345-9. English, French.

PMID:
16268434
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk